Literature DB >> 22170229

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.

Toshinari Yagi1, Jun Ishikawa, Nana Aono, Yukiko Yamashita, Shinsuke Kusakabe, Tetsuhiro Yoshinami, Yuki Akazawa, Daisuke Sakai, Sachiko Yamamoto, Yuri Hamanaka, Hiroaki Masaie, Naotoshi Sugimoto, Hitoshi Yoshida, Yasuhiko Tomita, Fumio Imamura.   

Abstract

A 56-year-old woman with Hodgkin-like adult T-cell leukemia/lymphoma was treated with allogeneic peripheral blood stem cell transplantation on 17 April 2009. She manifested a moderate fever on day 41. CT scanning and other examinations detected slightly swollen lymph nodes, and pathological findings of right axillary lymph nodes revealed an Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. She was successfully treated with rituximab.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22170229     DOI： 10.1007/s12185-011-0979-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  8 in total

1.  Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features.

Authors:  K Ohshima; J Suzumiya; A Kato; K Tashiro; M Kikuchi
Journal:  Int J Cancer       Date:  1997-08-07       Impact factor: 7.396

2.  Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

Authors:  A Faye; P Quartier; Y Reguerre; P Lutz; A S Carret; A Dehée; P Rohrlich; M Peuchmaur; A Matthieu-Boué; A Fischer; E Vilmer
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

3.  Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Authors:  R E Curtis; L B Travis; P A Rowlings; G Socié; D W Kingma; P M Banks; E S Jaffe; G E Sale; M M Horowitz; R P Witherspoon; D A Shriner; D J Weisdorf; H J Kolb; K M Sullivan; K A Sobocinski; R P Gale; R N Hoover; J F Fraumeni; H J Deeg
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

4.  CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

Authors:  I Kuehnle; M H Huls; Z Liu; M Semmelmann; R A Krance; M K Brenner; C M Rooney; H E Heslop
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

5.  A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Authors:  Y Yamada; M Tomonaga; H Fukuda; S Hanada; A Utsunomiya; M Tara; M Sano; S Ikeda; K Takatsuki; M Kozuru; K Araki; F Kawano; M Niimi; K Tobinai; T Hotta; M Shimoyama
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

6.  F-18 FDG PET/CT in the diagnosis of fever of unknown origin.

Authors:  Hans Balink; James Collins; George A Bruyn; George Bruyn; Filip Gemmel
Journal:  Clin Nucl Med       Date:  2009-12       Impact factor: 7.794

7.  Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma.

Authors:  K Tobinai; T Ohtsu; M Hayashi; T Kinoshita; Y Matsuno; K Mukai; M Shimoyama
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

8.  [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia].

Authors:  Yasuhiro Tanaka; Tadakazu Kondo; Wataru Kishimoto; Junya Kanda; Masaharu Tashima; Chisaki Mizumoto; Tatsuo Ichinohe; Takayuki Ishikawa; Takashi Uchiyama; Hironori Haga; Toshiaki Manabe
Journal:  Rinsho Ketsueki       Date:  2008-04
  8 in total
  3 in total

1.  Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.

Authors:  Taro Mohri; Yoshihiro Ikura; Asako Hirakoso; Masashi Okamoto; Masakatsu Hishizawa; Akifumi Takaori-Kondo; Seiichi Kato; Shigeo Nakamura; Kai Yoshimura; Hidetoshi Okabe; Yasuhiro Iwai
Journal:  Int J Hematol       Date:  2018-01-29       Impact factor: 2.490

2.  Adult T-cell lymphoma/leukaemia with haematemesis as a prodromal manifestation.

Authors:  Fariba Binesh; Mohamad Reza Mirjalili; Hasanali Vahedian; Hamidreza Bashiri
Journal:  BMJ Case Rep       Date:  2012-11-28

3.  Prolonged lymphocytosis as the first manifestation of Hodgkin-like adult T-cell leukemia/lymphoma.

Authors:  Achiléa L Bittencourt; Agnes Carvalho Andrade; Cristiane Requião; Maria da Gloria Bomfim Arruda; Iguaracyra Araújo
Journal:  Braz J Infect Dis       Date:  2016-10-24       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.